Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/10/18
End: 02/01/21
Due: 02/01/22
Phase: N/A
Priority: Normal
Start: 02/15/20
End: 12/15/22
Due: 12/15/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Tocilizumab for the Treatment of Refractory Behcet's Uveitis | NCT03554161 | Wenjie Zheng | user2@example.com | None | 2018-05-10 | 2021-02-01 | 2022-02-01 | - | - | 2025-07-14 |
| Golimumab for the Treatment of Refractory Behcet's Uveitis | NCT04218565 | Wenjie Zheng | user2@example.com | None | 2020-02-15 | 2022-12-15 | 2023-12-15 | - | - | 2025-07-14 |